Diapharma Revenue and Competitors
Estimated Revenue & Valuation
- Diapharma's estimated annual revenue is currently $5M per year.
- Diapharma's estimated revenue per employee is $155,000
Employee Data
- Diapharma has 32 Employees.
- Diapharma grew their employee count by 3% last year.
Diapharma's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Scientific Director | Reveal Email/Phone |
3 | Director Technical Operations | Reveal Email/Phone |
4 | QA/RA Manager | Reveal Email/Phone |
5 | Product Manager | Reveal Email/Phone |
6 | Commercial Business Development Manager | Reveal Email/Phone |
7 | Subject Matter Expert Instrumentation | Reveal Email/Phone |
8 | Senior Support Scientist | Reveal Email/Phone |
Diapharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $2M | 13 | 0% | N/A | N/A |
#3 | $0.8M | 5 | 0% | N/A | N/A |
#4 | $6.2M | 40 | 14% | N/A | N/A |
#5 | $68.7M | 443 | 6% | N/A | N/A |
#6 | $97.2M | 448 | 17% | $330M | N/A |
#7 | $1.9M | 12 | 9% | N/A | N/A |
#8 | $2.5M | 16 | 220% | N/A | N/A |
#9 | $7M | 45 | -6% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is Diapharma?
Diapharma Group, Inc. sells test kits, reagents, and instruments in the fields of thrombosis & haemostasis, platelet function analysis, apoptosis, and ecotoxicology. Founded in 1997, Diapharma has a full staff of technical representatives with expertise in clinical and research products, as well as a staff of customer service representatives dedicated to supporting customer needs. https://diapharma.com/company/
keywords:N/AN/A
Total Funding
32
Number of Employees
$5M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9M | 32 | -38% | N/A |
#2 | $4.5M | 32 | 68% | N/A |
#3 | $3.8M | 32 | 10% | N/A |
#4 | $3.7M | 32 | 0% | N/A |
#5 | $2.6M | 33 | 0% | N/A |